Format

Send to

Choose Destination
Pediatr Infect Dis J. 2017 Feb;36(2):230-231. doi: 10.1097/INF.0000000000001396.

Disseminated Fusariosis in Immunocompromised Children-Analysis of Recent Cases Identified in the Global Fungiscope Registry.

Author information

1
From the *Division of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, J.W. Goethe University, Frankfurt, Germany; †Klinik I für Innere Medizin, Klinikum der Universität zu Köln, Köln, Germany; ‡German Centre for Infection Research, Partner site Bonn-Cologne, Bonn, Germany; §Pediatric Hematology and Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy; ¶Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany; ‖Metchnikov North-Western State University, St. Petersburg, Russia; **Dmitry Rogachev Federal Scientific-Clinical Center of Children's Hematology, Oncology and Immunology, Moscow, Russia; ††Department of Medical Microbiology, Faculty of Medicine, Akdeniz University, Antalya, Turkey; and ‡‡Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.

Abstract

Disseminated fusariosis is a rare disease, and data are scant in pediatric patients. In the FungiScope registry, we identified 10 children with disseminated fusariosis between 2006 and 2015. Our analysis of the largest pediatric case series reported to date adds pediatric-specific experience to the management of this opportunistic infection in children.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT01731353.

PMID:
27846057
DOI:
10.1097/INF.0000000000001396
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center